annual CAPEX:
$7.44B+$1.80B(+31.85%)Summary
- As of today (August 20, 2025), NVO annual capital expenditures is $7.44 billion, with the most recent change of +$1.80 billion (+31.85%) on December 31, 2024.
- During the last 3 years, NVO annual CAPEX has risen by +$6.27 billion (+533.96%).
- NVO annual CAPEX is now at all-time high.
Performance
NVO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$2.44B+$381.15M(+18.52%)Summary
- As of today (August 20, 2025), NVO quarterly capital expenditures is $2.44 billion, with the most recent change of +$381.15 million (+18.52%) on June 1, 2025.
- Over the past year, NVO quarterly CAPEX has increased by +$526.17 million (+27.51%).
- NVO quarterly CAPEX is now at all-time high.
Performance
NVO quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$8.71B+$526.17M(+6.43%)Summary
- As of today (August 20, 2025), NVO TTM capital expenditures is $8.71 billion, with the most recent change of +$526.17 million (+6.43%) on June 1, 2025.
- Over the past year, NVO TTM CAPEX has increased by +$1.56 billion (+21.86%).
- NVO TTM CAPEX is now at all-time high.
Performance
NVO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.9% | +27.5% | +21.9% |
| 3 y3 years | +534.0% | +557.4% | +588.9% |
| 5 y5 years | +342.0% | +1108.1% | +591.8% |
NVO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +534.0% | at high | +557.4% | at high | +588.9% |
| 5 y | 5-year | at high | +534.0% | at high | +1108.1% | at high | +642.4% |
| alltime | all time | at high | >+9999.0% | at high | +5572.8% | at high | +7084.5% |
NVO CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.44B(+18.5%) | $8.71B(+6.4%) |
| Mar 2025 | - | $2.06B(-13.4%) | $8.19B(+10.0%) |
| Dec 2024 | $7.44B(+31.8%) | $2.38B(+29.0%) | $7.44B(-0.1%) |
| Sep 2024 | - | $1.84B(-3.7%) | $7.45B(+4.2%) |
| Jun 2024 | - | $1.91B(+45.9%) | $7.15B(+14.2%) |
| Mar 2024 | - | $1.31B(-45.0%) | $6.26B(+11.0%) |
| Dec 2023 | $5.64B(+170.8%) | $2.38B(+54.8%) | $5.64B(+37.3%) |
| Sep 2023 | - | $1.54B(+50.3%) | $4.11B(+30.0%) |
| Jun 2023 | - | $1.03B(+48.2%) | $3.16B(+26.1%) |
| Mar 2023 | - | $692.07M(-18.8%) | $2.51B(+20.3%) |
| Dec 2022 | $2.08B(+77.6%) | $851.89M(+43.7%) | $2.08B(+31.2%) |
| Sep 2022 | - | $592.90M(+59.8%) | $1.59B(+25.6%) |
| Jun 2022 | - | $371.00M(+38.2%) | $1.26B(+5.5%) |
| Mar 2022 | - | $268.37M(-24.8%) | $1.20B(+2.2%) |
| Dec 2021 | $1.17B(-65.2%) | $356.87M(+32.8%) | $1.17B(-58.3%) |
| Sep 2021 | - | $268.67M(-12.0%) | $2.81B(-18.9%) |
| Jun 2021 | - | $305.41M(+25.8%) | $3.47B(+3.1%) |
| Mar 2021 | - | $242.77M(-87.8%) | $3.37B(-0.3%) |
| Dec 2020 | $3.38B(+100.6%) | $2.00B(+115.9%) | $3.38B(+85.6%) |
| Sep 2020 | - | $924.56M(+357.9%) | $1.82B(+44.4%) |
| Jun 2020 | - | $201.89M(-20.5%) | $1.26B(-14.6%) |
| Mar 2020 | - | $254.05M(-42.1%) | $1.48B(-12.4%) |
| Dec 2019 | $1.68B(-14.3%) | $438.60M(+20.1%) | $1.68B(-9.5%) |
| Sep 2019 | - | $365.07M(-12.6%) | $1.86B(-4.5%) |
| Jun 2019 | - | $417.93M(-9.5%) | $1.95B(+0.5%) |
| Mar 2019 | - | $462.03M(-24.9%) | $1.94B(-1.3%) |
| Dec 2018 | $1.96B(+49.8%) | $615.16M(+35.7%) | $1.96B(+5.9%) |
| Sep 2018 | - | $453.30M(+11.2%) | $1.85B(+8.5%) |
| Jun 2018 | - | $407.64M(-16.5%) | $1.71B(+10.0%) |
| Mar 2018 | - | $488.18M(-3.4%) | $1.55B(+18.5%) |
| Dec 2017 | $1.31B(+6.8%) | $505.41M(+63.8%) | $1.31B(+8.2%) |
| Sep 2017 | - | $308.61M(+22.5%) | $1.21B(-6.2%) |
| Jun 2017 | - | $251.90M(+2.6%) | $1.29B(-1.0%) |
| Mar 2017 | - | $245.41M(-39.6%) | $1.31B(+6.3%) |
| Dec 2016 | $1.23B(+29.0%) | $406.12M(+4.6%) | $1.23B(+7.6%) |
| Sep 2016 | - | $388.25M(+46.3%) | $1.14B(+21.0%) |
| Jun 2016 | - | $265.31M(+57.3%) | $943.19M(+11.2%) |
| Mar 2016 | - | $168.62M(-47.1%) | $848.35M(+6.0%) |
| Dec 2015 | $952.40M(+34.1%) | $318.93M(+67.6%) | $800.00M(+6.9%) |
| Sep 2015 | - | $190.33M(+11.6%) | $748.43M(-0.4%) |
| Jun 2015 | - | $170.47M(+41.7%) | $751.70M(+1.0%) |
| Mar 2015 | - | $120.27M(-55.0%) | $744.58M(-3.5%) |
| Dec 2014 | $709.99M(+9.4%) | $267.36M(+38.1%) | $771.38M(+16.8%) |
| Sep 2014 | - | $193.60M(+18.5%) | $660.47M(+2.5%) |
| Jun 2014 | - | $163.35M(+11.1%) | $644.51M(+1.2%) |
| Mar 2014 | - | $147.07M(-6.0%) | $637.16M(-1.8%) |
| Dec 2013 | $648.69M(+3.8%) | $156.46M(-11.9%) | $648.69M(-5.9%) |
| Sep 2013 | - | $177.64M(+13.9%) | $689.23M(+0.2%) |
| Jun 2013 | - | $155.99M(-1.6%) | $688.20M(+0.5%) |
| Mar 2013 | - | $158.60M(-19.5%) | $684.69M(+9.6%) |
| Dec 2012 | $625.00M(+0.5%) | $197.00M(+11.5%) | $625.00M(-6.4%) |
| Sep 2012 | - | $176.61M(+15.8%) | $667.84M(+7.6%) |
| Jun 2012 | - | $152.49M(+54.2%) | $620.50M(+1.8%) |
| Mar 2012 | - | $98.91M(-58.8%) | $609.27M(-2.0%) |
| Dec 2011 | $621.96M | $239.84M(+85.5%) | $621.96M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $129.27M(-8.5%) | $628.46M(-4.8%) |
| Jun 2011 | - | $141.26M(+26.6%) | $660.02M(+1.4%) |
| Mar 2011 | - | $111.60M(-54.7%) | $651.05M(-6.0%) |
| Dec 2010 | $692.45M(+22.6%) | $246.33M(+53.2%) | $692.45M(+3.9%) |
| Sep 2010 | - | $160.83M(+21.6%) | $666.65M(+1.6%) |
| Jun 2010 | - | $132.29M(-13.5%) | $656.04M(+5.2%) |
| Mar 2010 | - | $153.00M(-30.6%) | $623.49M(+10.4%) |
| Dec 2009 | $564.86M(+46.0%) | $220.53M(+46.8%) | $564.86M(+17.6%) |
| Sep 2009 | - | $150.22M(+50.6%) | $480.51M(+2.3%) |
| Jun 2009 | - | $99.75M(+5.7%) | $469.75M(+7.2%) |
| Mar 2009 | - | $94.37M(-30.7%) | $438.19M(+13.3%) |
| Dec 2008 | $386.82M(-13.2%) | $136.17M(-2.4%) | $386.82M(-2.2%) |
| Sep 2008 | - | $139.46M(+104.5%) | $395.67M(+8.3%) |
| Jun 2008 | - | $68.19M(+58.6%) | $365.40M(-6.1%) |
| Mar 2008 | - | $42.99M(-70.4%) | $388.95M(-8.3%) |
| Dec 2007 | $445.70M(-20.1%) | $145.02M(+32.8%) | $424.02M(-6.4%) |
| Sep 2007 | - | $109.19M(+19.0%) | $453.23M(-0.8%) |
| Jun 2007 | - | $91.74M(+17.5%) | $456.85M(-2.8%) |
| Mar 2007 | - | $78.07M(-55.2%) | $469.83M(-3.7%) |
| Dec 2006 | $558.17M(-19.6%) | $174.23M(+54.4%) | $487.66M(-8.0%) |
| Sep 2006 | - | $112.82M(+7.7%) | $529.88M(-11.6%) |
| Jun 2006 | - | $104.71M(+9.2%) | $599.17M(-3.1%) |
| Mar 2006 | - | $95.91M(-55.7%) | $618.47M(-4.8%) |
| Dec 2005 | $693.89M(+20.4%) | $216.44M(+18.9%) | $649.89M(+1.0%) |
| Sep 2005 | - | $182.10M(+46.8%) | $643.52M(+6.3%) |
| Jun 2005 | - | $124.02M(-2.6%) | $605.10M(+14.1%) |
| Mar 2005 | - | $127.32M(-39.4%) | $530.20M(+1.2%) |
| Dec 2004 | $576.26M(+51.3%) | $210.07M(+46.2%) | $524.16M(+66.9%) |
| Sep 2004 | - | $143.68M(+192.5%) | $314.08M(+84.3%) |
| Jun 2004 | - | $49.12M(-59.5%) | $170.40M(+40.5%) |
| Mar 2004 | - | $121.28M | $121.28M |
| Dec 2003 | $380.84M(-24.2%) | - | - |
| Dec 2002 | $502.14M(+6.1%) | - | - |
| Dec 2001 | $473.33M(+61.9%) | - | - |
| Dec 2000 | $292.31M(+5.9%) | - | - |
| Dec 1999 | $275.92M(-13.6%) | - | - |
| Dec 1998 | $319.32M(-17.1%) | - | - |
| Dec 1997 | $385.14M(+20.9%) | - | - |
| Dec 1996 | $318.57M(+19.0%) | - | - |
| Dec 1995 | $267.66M(-2.1%) | - | - |
| Dec 1994 | $273.50M(-25.9%) | - | - |
| Dec 1993 | $368.95M(+13.7%) | - | - |
| Dec 1992 | $324.63M(+54.1%) | - | - |
| Dec 1991 | $210.60M(+11.1%) | - | - |
| Dec 1990 | $189.51M(+64.8%) | - | - |
| Dec 1989 | $115.01M(-0.7%) | - | - |
| Dec 1988 | $115.84M(+0.9%) | - | - |
| Dec 1987 | $114.80M(+18.3%) | - | - |
| Dec 1986 | $97.01M(+50.1%) | - | - |
| Dec 1985 | $64.63M(+5.8%) | - | - |
| Dec 1984 | $61.06M(-0.8%) | - | - |
| Dec 1983 | $61.52M(+3.7%) | - | - |
| Dec 1982 | $59.35M(+39.6%) | - | - |
| Dec 1981 | $42.52M(+19.2%) | - | - |
| Dec 1980 | $35.68M | - | - |
FAQ
- What is Novo Nordisk A/S annual capital expenditures?
- What is the all time high annual CAPEX for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual CAPEX year-on-year change?
- What is Novo Nordisk A/S quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly CAPEX year-on-year change?
- What is Novo Nordisk A/S TTM capital expenditures?
- What is the all time high TTM CAPEX for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM CAPEX year-on-year change?
What is Novo Nordisk A/S annual capital expenditures?
The current annual CAPEX of NVO is $7.44B
What is the all time high annual CAPEX for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual capital expenditures is $7.44B
What is Novo Nordisk A/S annual CAPEX year-on-year change?
Over the past year, NVO annual capital expenditures has changed by +$1.80B (+31.85%)
What is Novo Nordisk A/S quarterly capital expenditures?
The current quarterly CAPEX of NVO is $2.44B
What is the all time high quarterly CAPEX for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly capital expenditures is $2.44B
What is Novo Nordisk A/S quarterly CAPEX year-on-year change?
Over the past year, NVO quarterly capital expenditures has changed by +$526.17M (+27.51%)
What is Novo Nordisk A/S TTM capital expenditures?
The current TTM CAPEX of NVO is $8.71B
What is the all time high TTM CAPEX for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM capital expenditures is $8.71B
What is Novo Nordisk A/S TTM CAPEX year-on-year change?
Over the past year, NVO TTM capital expenditures has changed by +$1.56B (+21.86%)